当前位置: 首页 > 期刊 > 《中国现代医生》 > 2019年第22期
编号:13415220
鞘内注射化疗药物治疗急性T淋巴细胞白血病的护理干预(1)
http://www.100md.com 2019年8月5日 《中国现代医生》 2019年第22期
     [摘要] 目的 探討鞘内注射化疗药物应用于治疗急性T淋巴细胞白血病患者的护理干预措施。 方法 回顾性分析我院从2016年8月~2018年4月间收入的所有急性T淋巴细胞白血病患者的一般资料,所有患者均采用鞘内注射化疗药物进行治疗。根据本实验要求,选取66例患者纳入本次研究开展实验,通过双色球分组法,将所有患者均分为对照组和实验组,每组33例。对照组患者采用常规护理干预方案,实验组患者则做好相应的治疗护理干预,对比两组患者的治疗不良反应、护理满意度以及生活质量评分。 结果 实验结果显示,实验组患者的不良反应发生率为18.18%,对照组患者的不良反应发生率为39.39%;实验组患者的护理满意度高于对照组,差异有统计学意义(P<0.05),实验组患者的生活质量评分高于对照组,差异有统计学意义(P<0.05)。 结论 在对急性T淋巴细胞白血病患者进行治疗时,应用鞘内注射化疗药物进行治疗,并配合相应的护理干预,能够取得较好的治疗效果,对于提高患者的护理满意度,降低患者不良事件发生率来说有积极意义,有助于提高患者的生活质量,使患者以健康的状态配合护理工作的开展。

    [关键词] 鞘内注射;T淋巴细胞白血病;护理干预;不良反应;生活质量

    [中图分类号] R473.5 [文献标识码] B [文章编号] 1673-9701(2019)22-0147-04

    [Abstract] Objective To explore the nursing intervention for intrathecal injection of chemotherapy drugs for acute T lymphocytic leukemia. Methods A retrospective analysis of the general data of all patients with acute T-lymphocytic leukemia who were admitted to our hospital from August 2016 to April 2018 was performed. All patients were treated with intrathecal chemotherapy. According to the requirements of this experiment, 66 patients were enrolled in this study, and all patients were divided into control group and experimental group, respectively, by two-color ball grouping method, 33 cases in each group. Patients in the control group were treated with routine nursing intervention, and patients in the experimental group were treated with appropriate nursing intervention. The adverse reactions, nursing satisfaction and quality of life scores of the two groups were compared. Results The experimental results showed that the incidence of adverse reactions in the experimental group was 18.18%, and the incidence of adverse reactions in the control group was 39.39%. The satisfaction of the patients in the experimental group was higher than that in the control group, which was statistically significant(P<0.05). The quality of life scores of the experimental group were higher than those of the control group, and the difference between the groups was statistically significant(P<0.05). Conclusion In the treatment of patients with acute T-lymphocytic leukemia, intrathecal injection of chemotherapy drugs combined with corresponding nursing interventions can achieve better therapeutic results, improve patients' satisfaction and reduce the incidence of adverse events. It also helps to improve the quality of life of patients, thereby improving patients' care compliance.

    [Key words] Intrathecal injection;T-lymphocytic leukemia;Nursing intervention;Adverse reactions;Quality of life, 百拇医药(季丽 刘永华 徐叶惠 谢莹芳)
1 2 3 4下一页